Bill

Bill > S3216


US S3216

US S3216
Access to Breast Cancer Diagnosis Act of 2020


summary

Introduced
01/16/2020
In Committee
01/16/2020
Crossed Over
Passed
Dead
12/31/2020

Introduced Session

116th Congress

Bill Summary

A bill to amend title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements or treatment limitations with respect to diagnostic examinations for breast cancer that are less favorable than such requirements with respect to screening examinations for breast cancer. This bill prohibits private health insurance plans from imposing higher cost-sharing requirements on breast cancer diagnostic examinations than initial breast cancer screening examinations. Diagnostic examinations are generally required after an initial screening detects an abnormality and typically require additional mammogram images (e.g., x-rays).

AI Summary

This bill, the Access to Breast Cancer Diagnosis Act of 2020, prohibits private health insurance plans from imposing higher cost-sharing requirements or treatment limitations on breast cancer diagnostic examinations compared to initial breast cancer screening examinations. Diagnostic examinations are generally required after an initial screening detects an abnormality and typically require additional mammogram images. The bill amends the Public Health Service Act to ensure that cost-sharing and treatment limitations for diagnostic examinations are no less favorable than those for screening examinations. The amendments will apply to plan years beginning on or after January 1, 2021.

Committee Categories

Health and Social Services

Sponsors (2)

Last Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (on 01/16/2020)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...